Literature DB >> 22013555

The first line of intra-abdominal metastatic attack: breaching the mesothelial cell layer.

Hilary A Kenny1, Kristin M Nieman, Anirban K Mitra, Ernst Lengyel.   

Abstract

Iwanicki and colleagues reveal that ovarian cancer spheroids clear mesothelial cells which cover the surface of the abdominal cavity using myosin-generated force.

Entities:  

Mesh：

Year:  2011        PMID： 22013555      PMCID： PMC3193939          DOI： 10.1158/2159-8290.CD-11-0117

Source DB:  PubMed          Journal:  Cancer Discov        ISSN： 2159-8274            Impact factor:   39.397


  12 in total

Review 1.  Adhesion-dependent cell mechanosensitivity.

Authors:  Alexander D Bershadsky; Nathalie Q Balaban; Benjamin Geiger
Journal:  Annu Rev Cell Dev Biol       Date:  2003       Impact factor: 13.827

2.  Ovarian cancer spheroids use myosin-generated force to clear the mesothelium.

Authors:  Marcin P Iwanicki; Rachel A Davidowitz; Mei Rosa Ng; Achim Besser; Taru Muranen; Melissa Merritt; Gaudenz Danuser; Tan A Ince; Tan Ince; Joan S Brugge
Journal:  Cancer Discov       Date:  2011-07       Impact factor: 39.397

3.  Characteristics and growth patterns of human peritoneal mesothelial cells: comparison between advanced epithelial ovarian cancer and non-ovarian cancer sources.

Authors:  X Y Zhang; R Pettengell; N Nasiri; V Kalia; A G Dalgleish; D P Barton
Journal:  J Soc Gynecol Investig       Date:  1999 Nov-Dec

4.  Cancer statistics, 2010.

Authors:  Ahmedin Jemal; Rebecca Siegel; Jiaquan Xu; Elizabeth Ward
Journal:  CA Cancer J Clin       Date:  2010-07-07       Impact factor: 508.702

5.  Ovarian cancer development and metastasis.

Authors:  Ernst Lengyel
Journal:  Am J Pathol       Date:  2010-07-22       Impact factor: 4.307

6.  Interactions of human ovarian tumor cells with human mesothelial cells grown on extracellular matrix. An in vitro model system for studying tumor cell adhesion and invasion.

Authors:  M J Niedbala; K Crickard; R J Bernacki
Journal:  Exp Cell Res       Date:  1985-10       Impact factor: 3.905

7.  Endostatin binding to ovarian cancer cells inhibits peritoneal attachment and dissemination.

Authors:  Yumi Yokoyama; Gerald Sedgewick; S Ramakrishnan
Journal:  Cancer Res       Date:  2007-11-15       Impact factor: 12.701

8.  Senescent peritoneal mesothelial cells promote ovarian cancer cell adhesion: the role of oxidative stress-induced fibronectin.

Authors:  Krzysztof Ksiazek; Justyna Mikula-Pietrasik; Katarzyna Korybalska; Grzegorz Dworacki; Achim Jörres; Janusz Witowski
Journal:  Am J Pathol       Date:  2009-02-26       Impact factor: 4.307

9.  Use of a novel 3D culture model to elucidate the role of mesothelial cells, fibroblasts and extra-cellular matrices on adhesion and invasion of ovarian cancer cells to the omentum.

Authors:  Hilary A Kenny; Thomas Krausz; Seiko D Yamada; Ernst Lengyel
Journal:  Int J Cancer       Date:  2007-10-01       Impact factor: 7.396

10.  Tumour-induced apoptosis in human mesothelial cells: a mechanism of peritoneal invasion by Fas Ligand/Fas interaction.

Authors:  R M Heath; D G Jayne; R O'Leary; E E Morrison; P J Guillou
Journal:  Br J Cancer       Date:  2004-04-05       Impact factor: 7.640
View more
  37 in total

Review 1.  Epithelial ovarian cancer experimental models.

Authors:  E Lengyel; J E Burdette; H A Kenny; D Matei; J Pilrose; P Haluska; K P Nephew; D B Hales; M S Stack
Journal:  Oncogene       Date:  2013-08-12       Impact factor: 9.867

2.  Mesenchymal gene program-expressing ovarian cancer spheroids exhibit enhanced mesothelial clearance.

Authors:  Rachel A Davidowitz; Laura M Selfors; Marcin P Iwanicki; Kevin M Elias; Alison Karst; Huiying Piao; Tan A Ince; Michael G Drage; Judy Dering; Gottfried E Konecny; Ursula Matulonis; Gordon B Mills; Dennis J Slamon; Ronny Drapkin; Joan S Brugge
Journal:  J Clin Invest       Date:  2014-04-24       Impact factor: 14.808

3.  In vitro mesothelial clearance assay that models the early steps of ovarian cancer metastasis.

Authors:  Rachel A Davidowitz; Marcin P Iwanicki; Joan S Brugge
Journal:  J Vis Exp       Date:  2012-02-17       Impact factor: 1.355

4.  Mutant p53 regulates ovarian cancer transformed phenotypes through autocrine matrix deposition.

Authors:  Marcin P Iwanicki; Hsing-Yu Chen; Claudia Iavarone; Ioannis K Zervantonakis; Taru Muranen; Marián Novak; Tan A Ince; Ronny Drapkin; Joan S Brugge
Journal:  JCI Insight       Date:  2016-07-07

Review 5.  Development of Peritoneal Carcinomatosis in Epithelial Ovarian Cancer: A Review.

Authors:  Juliette O A M van Baal; Cornelis J F van Noorden; Rienk Nieuwland; Koen K Van de Vijver; Auguste Sturk; Willemien J van Driel; Gemma G Kenter; Christianne A R Lok
Journal:  J Histochem Cytochem       Date:  2017-11-22       Impact factor: 2.479

6.  Small Molecules Target the Interaction between Tissue Transglutaminase and Fibronectin.

Authors:  Livia Elena Sima; Bakhtiyor Yakubov; Sheng Zhang; Salvatore Condello; Arabela A Grigorescu; Nkechiyere G Nwani; Lan Chen; Gary E Schiltz; Constandina Arvanitis; Zhong-Yin Zhang; Daniela Matei
Journal:  Mol Cancer Ther       Date:  2019-04-23       Impact factor: 6.261

7.  Modeling the Early Steps of Ovarian Cancer Dissemination in an Organotypic Culture of the Human Peritoneal Cavity.

Authors:  Peter C Hart; Preety Bajwa; Hilary A Kenny
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 8.  Three-dimensional modeling of ovarian cancer.

Authors:  Erin A White; Hilary A Kenny; Ernst Lengyel
Journal:  Adv Drug Deliv Rev       Date:  2014-07-14       Impact factor: 15.470

9.  Mesothelial cells promote early ovarian cancer metastasis through fibronectin secretion.

Authors:  Hilary A Kenny; Chun-Yi Chiang; Erin A White; Elizabeth M Schryver; Mohammed Habis; Iris L Romero; Andras Ladanyi; Carla V Penicka; Joshy George; Karl Matlin; Anthony Montag; Kristen Wroblewski; S Diane Yamada; Andrew P Mazar; David Bowtell; Ernst Lengyel
Journal:  J Clin Invest       Date:  2014-09-09       Impact factor: 14.808

10.  Differential roles of uPAR in peritoneal ovarian carcinomatosis.

Authors:  Nada N Al-Hassan; Ali Behzadian; Ruth Caldwell; Vessela S Ivanova; Viqar Syed; Kouros Motamed; Neveen A Said
Journal:  Neoplasia       Date:  2012-04       Impact factor: 5.715
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.